精神分裂症及相关障碍的表观遗传修饰:环境暴露的分子瘢痕与表型变异性来源
本文综述了精神分裂症及相关发育性精神障碍中表观遗传改变的临床与临床前研究发现,并讨论其可能来源。部分风险位点可通过表观遗传过程影响基因表达的随机变异,而相当一部分表观遗传改变可能由环境因素获得并表现为分子「瘢痕」,可影响全生命周期脑功能甚至跨代表观遗传传递。表观遗传修饰是表型异质性的可能分子来源,并可作为治疗干预靶点。
要点
- 精神分裂症风险位点可通过表观遗传过程影响基因表达的随机变异。
- 环境因素获得的表观遗传「瘢痕」可影响全生命周期脑功能并可能跨代传递。
- 表观遗传修饰是表型异质性的可能分子来源及治疗干预靶点。
核心结论
- 表观遗传修饰可能参与精神分裂症及相关发育性精神障碍的病因与病理生理。
- 表观遗传改变可由遗传因素或环境因素引起,是表型异质性的可能分子来源并可作为治疗干预靶点。
- 进一步阐明表观遗传修饰可能增进对精神分裂症异质性病因与病理生理的理解,并长期推动生物标志物指导的个性化表观遗传干预。
研究设计与样本
- 综述类文章,总结精神分裂症及相关疾病模型中的临床与临床前表观遗传改变发现。
主要发现
- 近期发现提示某些精神分裂症风险位点可通过表观遗传过程影响基因表达的随机变异。
- 相当一部分表观遗传改变可能通过环境因素获得并表现为分子「瘢痕」。
- 部分分子「瘢痕」可影响全生命周期脑功能,甚至通过表观遗传种系遗传递跨代传递。
临床怎么用
- 表观遗传修饰可作为治疗干预靶点,长期可能通过生物标志物指导的表观遗传干预推进个性化治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epigenetic modifications are increasingly recognized to play a role in the etiology and pathophysiology of schizophrenia and other psychiatric disorders with developmental origins. Here, we summarize clinical and preclinical findings of epigenetic alterations in schizophrenia and relevant disease models and discuss their putative origin. Recent findings suggest that certain schizophrenia risk loci can influence stochastic variation in gene expression through epigenetic processes, highlighting the intricate interaction between genetic and epigenetic control of neurodevelopmental trajectories. In addition, a substantial portion of epigenetic alterations in schizophrenia and related disorders may be acquired through environmental factors and may be manifested as molecular "scars." Some of these scars can influence brain functions throughout the entire lifespan and may even be transmitted across generations via epigenetic germline inheritance. Epigenetic modifications, whether caused by genetic or environmental factors, are plausible molecular sources of phenotypic heterogeneity and offer a target for therapeutic interventions. The further elucidation of epigenetic modifications thus may increase our knowledge regarding schizophrenia's heterogeneous etiology and pathophysiology and, in the long term, may advance personalized treatments through the use of biomarker-guided epigenetic interventions.
引用
- Richetto J, Meyer U. Epigenetic Modifications in Schizophrenia and Related Disorders: Molecular Scars of Environmental Exposures and Source of Phenotypic Variability. Biol Psychiatry. 2020. PMID: 32381277. doi:10.1016/j.biopsych.2020.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。